rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    CRVS
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Corvus Pharma Q3 2026 Earnings Call Transcript
      Nov 5BenzingaCRVS
      Corvus Pharma Q2 2026 Earnings Call Transcript - Corvus Pharmaceuticals (NASDAQ:CRVS)

      Corvus Pharma (NASDAQ:CRVS) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you by

      Oct 12BenzingaCRVS
      Corvus Pharmaceuticals (CRVS) Faces A Valuation Test, Is The Upside Already Priced In?
      Sep 25Yahoo FinanceCRVS
      Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial

      Data supports ongoing registration Phase 3 trial in r/r PTCL, Phase 2 trial in atopic dermatitis and planned trials for hidradenitis suppurativa and...

      Aug 27BarchartCRVS

      This is the newest page. Registered accounts read further back.